ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 9 filers reported holding ESSA PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,000 | +100.0% | 1,498 | +93.3% | 0.00% | – |
| Q2 2023 | $2,000 | 0.0% | 775 | 0.0% | 0.00% | – |
| Q1 2023 | $2,000 | -60.0% | 775 | -56.1% | 0.00% | – |
| Q4 2022 | $5,000 | -50.0% | 1,765 | -69.4% | 0.00% | – |
| Q3 2022 | $10,000 | -56.5% | 5,765 | -22.0% | 0.00% | – |
| Q2 2022 | $23,000 | -50.0% | 7,395 | 0.0% | 0.00% | – |
| Q1 2022 | $46,000 | -54.9% | 7,395 | +2.8% | 0.00% | – |
| Q4 2021 | $102,000 | +142.9% | 7,195 | +38.5% | 0.00% | – |
| Q3 2021 | $42,000 | -77.3% | 5,195 | -19.6% | 0.00% | – |
| Q2 2021 | $185,000 | -5.6% | 6,465 | -4.5% | 0.00% | – |
| Q1 2021 | $196,000 | +476.5% | 6,768 | +136.0% | 0.00% | – |
| Q4 2020 | $34,000 | +78.9% | 2,868 | +5.7% | 0.00% | – |
| Q3 2020 | $19,000 | +35.7% | 2,713 | +19.7% | 0.00% | – |
| Q2 2020 | $14,000 | 0.0% | 2,267 | -34.2% | 0.00% | – |
| Q1 2020 | $14,000 | -33.3% | 3,443 | -6.3% | 0.00% | – |
| Q4 2019 | $21,000 | +50.0% | 3,675 | -9.6% | 0.00% | – |
| Q3 2019 | $14,000 | +133.3% | 4,065 | +76.2% | 0.00% | – |
| Q2 2019 | $6,000 | -25.0% | 2,307 | -4.5% | 0.00% | – |
| Q1 2019 | $8,000 | +60.0% | 2,416 | +2.6% | 0.00% | – |
| Q4 2018 | $5,000 | -37.5% | 2,354 | -6.4% | 0.00% | – |
| Q3 2018 | $8,000 | -11.1% | 2,514 | +11.6% | 0.00% | – |
| Q2 2018 | $9,000 | – | 2,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,287,094 | $13,247,120 | 1.22% |
| BVF INC/IL | 8,748,629 | $27,033,264 | 0.73% |
| PFM Health Sciences, LP | 4,199,253 | $12,975,692 | 0.61% |
| Bellevue Group AG | 7,898,583 | $24,406,621 | 0.39% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,101,585 | 0.12% |
| Rock Springs Capital Management LP | 677,005 | $2,091,945 | 0.06% |
| Orbimed Advisors | 842,366 | $2,602,911 | 0.06% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,098 | 0.05% |
| Hunting Hill Global Capital, LLC | 10,000 | $30,900 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | $3,221,421 | 0.01% |